openPR Logo
Press release

Optic Nerve Diseases Market to Reach USD 7.9 Billion by 2034

09-23-2025 02:09 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Optic Nerve Diseases

Optic Nerve Diseases

The optic nerve is a crucial structure transmitting visual information from the retina to the brain. Optic nerve diseases include a wide spectrum of conditions such as glaucoma, optic neuritis, ischemic optic neuropathy, traumatic optic neuropathy, hereditary optic neuropathies, and compressive optic neuropathies. These disorders often lead to vision impairment, blindness, or neurological complications if left untreated.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72269

Rising incidence of glaucoma (a leading cause of irreversible blindness), autoimmune diseases, and neurodegenerative conditions, alongside advances in imaging and biologics, are shaping the optic nerve diseases market.

Market Overview
• Market Size (2024): USD 3.8 billion
• Forecast (2034): USD 7.9 billion
• CAGR (2025-2034): 7.6%

Key Highlights:
• Glaucoma remains the largest sub-segment, accounting for over half of market revenues.
• Increasing prevalence of optic neuritis linked to multiple sclerosis (MS).
• Advances in neuroprotective therapies, stem cell research, and biologics.
• Rising adoption of AI-powered retinal and optic nerve imaging for early detection.

Segmentation Analysis
By Disease Type:
• Glaucoma (largest)
• Optic Neuritis (autoimmune, MS-associated)
• Ischemic Optic Neuropathy
• Hereditary Optic Neuropathies (Leber's hereditary optic neuropathy, dominant optic atrophy)
• Traumatic Optic Neuropathy
• Compressive & Other Optic Nerve Disorders

By Treatment Type:
• Medications
o Corticosteroids (optic neuritis, inflammation)
o Immunosuppressants & Biologics (autoimmune-related)
o Neuroprotective Drugs (pipeline)

• Surgical & Procedural
o Glaucoma Surgeries & Implants
o Optic Nerve Decompression Surgery
o Neuro-Ophthalmic Procedures

• Emerging Therapies
o Stem Cell & Regenerative Therapies
o Gene Therapy (for hereditary optic neuropathies)

By End Use:
• Hospitals & Specialty Eye Clinics
• Ambulatory Surgical Centers
• Neurology & Neuro-Ophthalmology Centers
• Research & Academic Institutes

Segmentation Summary:
Glaucoma drives the majority of demand, but optic neuritis and hereditary optic neuropathies are gaining importance due to biologics and gene therapy advancements.

Explore Full Report here: https://exactitudeconsultancy.com/reports/72269/optic-nerve-diseases-market

Regional Analysis
North America
• Largest market (~43% share in 2024).
• High glaucoma prevalence and strong adoption of biologics for MS-related optic neuritis.
• Strong R&D ecosystem for stem cell and neuroprotective therapies.
Europe
• ~30% share.
• Germany, UK, and France leading in optic neuritis and neuro-ophthalmology trials.
• EMA support for orphan optic neuropathies.
Asia-Pacific
• Fastest-growing region, CAGR ~8.8%.
• Rising glaucoma cases in aging populations (China, Japan, India).
• Expanding access to advanced imaging and surgical care.
Latin America
• Brazil and Mexico strengthening glaucoma and optic nerve disease care.
Middle East & Africa
• GCC countries adopting advanced diagnostics.
• Limited specialist availability in low-income countries contributing to unmet need.
Regional Summary:
North America and Europe dominate, but Asia-Pacific will grow fastest due to a large patient base and expanding healthcare access.

Market Dynamics
Key Growth Drivers:
• Rising global prevalence of glaucoma and autoimmune-related optic neuritis.
• Increasing use of AI and advanced imaging (OCT, MRI) for early diagnosis.
• Advancements in stem cell therapy, neuroprotection, and gene therapy.
• Growing demand for multidisciplinary neuro-ophthalmology care.

Key Challenges:
• Irreversible vision loss in late-diagnosed cases.
• Limited efficacy of current neuroprotective therapies.
• High costs of biologics and emerging therapies.
• Underdiagnosis in developing regions.

Latest Trends:
• Expansion of minimally invasive glaucoma surgeries (MIGS).
• Development of gene therapies for hereditary optic neuropathies (e.g., LHON).
• Clinical trials in neuroprotective agents for optic nerve preservation.
• Increasing integration of tele-ophthalmology and AI-based screening.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72269

Competitor Analysis
Major Players in the Market:
• Novartis AG
• AbbVie Inc. (Allergan)
• Regeneron Pharmaceuticals, Inc.
• Biogen Inc.
• Santen Pharmaceutical Co., Ltd.
• Bausch + Lomb
• Alcon Inc.
• GenSight Biologics (LHON gene therapy pipeline)
• Roche Holding AG
• Teva Pharmaceutical Industries Ltd.

Competitive Summary:
Novartis, AbbVie, and Alcon dominate glaucoma and optic neuritis therapies. Biogen and Regeneron lead in autoimmune optic nerve treatment, while GenSight Biologics is pioneering gene therapy for hereditary optic neuropathies. Surgical players like Alcon and Bausch drive glaucoma device innovation.

Conclusion
The Optic Nerve Diseases Market, valued at USD 3.8 billion in 2024, is projected to reach USD 7.9 billion by 2034, expanding at a CAGR of 7.6%.

Key Takeaways:
• Glaucoma remains the largest contributor, but autoimmune and hereditary optic neuropathies are fast-growing segments.
• North America and Europe dominate, while Asia-Pacific shows the fastest growth.
• Innovation in gene therapy, stem cell treatments, and AI diagnostics will transform care delivery.
• Multidisciplinary neuro-ophthalmology centers will expand patient access to advanced treatments.

The next decade will bring a paradigm shift from symptomatic control to regenerative and gene-based therapies, reshaping the future of optic nerve disease management.

This report is also available in the following languages : Japanese (視神経疾患市場), Korean (시신경 질환 시장), Chinese (视神经疾病市场), French (Marché des maladies du nerf optique), German (Markt für Sehnervenerkrankungen), and Italian (Mercato delle malattie del nervo ottico), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72269/optic-nerve-diseases-market#request-a-sample

Our More Reports:

Friedreich's Ataxia Market
https://exactitudeconsultancy.com/reports/72874/friedreich-s-ataxia-market

Catheter-related Bloodstream Infections Market
https://exactitudeconsultancy.com/reports/72875/catheter-related-bloodstream-infections-market

Blockbuster Drugs Market
https://exactitudeconsultancy.com/reports/72876/blockbuster-drugs-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Optic Nerve Diseases Market to Reach USD 7.9 Billion by 2034 here

News-ID: 4194260 • Views:

More Releases from Exactitude Consultancy

Gene Therapy in Ophthalmology Market Set to Surge at 14.8% CAGR, Reaching USD 6.5 Billion by 2034
Gene Therapy in Ophthalmology Market Set to Surge at 14.8% CAGR, Reaching USD 6. …
Introduction Gene therapy is revolutionizing ophthalmology by offering the potential to treat and even cure previously untreatable genetic eye diseases. By targeting the underlying genetic defects responsible for conditions such as retinitis pigmentosa, Leber congenital amaurosis (LCA), X-linked retinitis pigmentosa (XLRP), and Stargardt disease, gene therapy is reshaping the future of vision care. Unlike traditional therapies that only manage symptoms, gene therapies aim to restore or preserve vision by repairing defective genes
Panuveitis Market to Reach USD 2.9 Billion by 2034
Panuveitis Market to Reach USD 2.9 Billion by 2034
Panuveitis is a severe form of uveitis in which all layers of the uvea (iris, ciliary body, and choroid) are inflamed. It often results in blurred vision, eye pain, redness, light sensitivity, and floaters. The condition can be triggered by autoimmune diseases, infections, or idiopathic causes, and if untreated, can cause irreversible vision loss, glaucoma, cataracts, and retinal complications. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72271 The increasing prevalence
Tonometers Market Projected to Grow at 7.3% CAGR, Reaching USD 730 Million by 2034
Tonometers Market Projected to Grow at 7.3% CAGR, Reaching USD 730 Million by 20 …
Introduction Tonometers are essential ophthalmic diagnostic devices used to measure intraocular pressure (IOP), a key risk factor for glaucoma. Early detection of elevated IOP is critical, as glaucoma is one of the leading causes of irreversible blindness worldwide. Regular screening through tonometry allows ophthalmologists to diagnose and manage the disease before significant vision loss occurs. The tonometers market is evolving with the introduction of non-contact (air-puff) devices, handheld portable solutions, digital
Ophthalmoscopes Market Poised to Grow at 7.2% CAGR, Reaching USD 640 Million by 2034
Ophthalmoscopes Market Poised to Grow at 7.2% CAGR, Reaching USD 640 Million by …
Introduction Ophthalmoscopes are essential diagnostic instruments used by ophthalmologists and optometrists to examine the interior of the eye, particularly the retina, optic nerve, and blood vessels. These devices play a critical role in detecting and monitoring conditions such as glaucoma, diabetic retinopathy, macular degeneration, hypertension-related changes, and other retinal disorders. The global demand for ophthalmoscopes is expanding due to the rising prevalence of eye diseases, aging populations, and growing emphasis on early

All 5 Releases


More Releases for Optic

Enhancing Fiber Optic Network Efficiency: Innovations in MPO Patch Cords and Fib …
As the demand for data transmission continues to grow, businesses and service providers are placing higher expectations on the reliability and efficiency of fiber optic networks. In response, innovations in MPO patch cords [https://www.sdgicable.com/products-detail/id-30.html] and fiber optic splitters [https://www.sdgicable.com/products-detail/Fiber-Optic-Splitter.html ] have emerged as key solutions for optimizing fiber optic networks. These advancements not only increase transmission speed and reliability but also simplify cabling systems, offering more efficient solutions for data
Fiber Optic Ring for Fiber Optic Gyro Market Research Report | Valuates Reports
Fiber Optic Ring for Fiber Optic Gyro Market Research Report | Valuates Reports Fiber Optic Ring for Fiber Optic Gyro is the fiber optic ring applied to fiber optic gyroscope manufacturing. The global Fiber Optic Ring for Fiber Optic Gyro market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Fiber Optic
Fiber optic adhesives glue for fiber optic cable assembly and their benefits
Fiber optic adhesives glue for fiber optic cable assembly and their benefits Adhesives for fiber optic are an important part of the whole system as they play a very integral role. These adhesives can act as coatings and sealants in fiber optic devices. Some of the most common applications of adhesives for fiber optics include: Handling Vgroove types of assemblies Field and splices repairs Bonding the fiber optic bundles to ferrules Potting the fiber optic
Global fiber optic connectivity market | fibre broadband, fiber internet, fiber …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Global Fiber Optic Connectivity Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. The fiber optic connectivity market report provides analysis for the period 2016
Global Presents Fiber-optic Filters Market Growth and Forecast 2018 to 2028(Segm …
Fiber-optic filters market: Market Overview Due to increasing reliance of organizations on IT (Information Technology), the demand for robust, agile and cost effective IT infrastructure is growing rapidly. The fabric-optic filter market is expanding rapidly as the telecom service providers in this modern era are moving towards fiber-based networking services. Increasing advancements in telecom industry is one of the major factors driving the growth of the fiber-optic filter market worldwide. Furthermore,
Fiber-optic couplers Market Segmentation By Type Y Fiber-optic Couplers, T Fiber …
Fiber-optic couplers market: Market Overview Due to increasing reliance of organizations on IT, the demand for robust, agile and cost effective IT infrastructure is growing rapidly and supporting the Fiber-optic couplers market. The fabric-optic couplers market is expanding rapidly as the telecom services providers in this modern era are moving towards fiber based networking services. Increasing advancements in the telecom industry are one of the major factors driving the growth of